Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antigens, Helminth | 34 | 2024 | 190 | 4.600 |
Why?
|
Helminth Proteins | 27 | 2024 | 101 | 3.390 |
Why?
|
Trichinella spiralis | 20 | 2024 | 22 | 2.990 |
Why?
|
Ancylostoma | 21 | 2018 | 98 | 2.480 |
Why?
|
Ascariasis | 7 | 2021 | 73 | 2.180 |
Why?
|
Protozoan Vaccines | 11 | 2021 | 96 | 1.850 |
Why?
|
Necator americanus | 12 | 2018 | 91 | 1.530 |
Why?
|
Vaccines | 13 | 2022 | 366 | 1.520 |
Why?
|
Recombinant Proteins | 32 | 2023 | 1400 | 1.360 |
Why?
|
Trichinellosis | 11 | 2024 | 14 | 1.350 |
Why?
|
Antibodies, Helminth | 20 | 2021 | 125 | 1.270 |
Why?
|
Ancylostomiasis | 14 | 2018 | 62 | 1.270 |
Why?
|
Onchocerciasis | 4 | 2022 | 20 | 1.180 |
Why?
|
Ascaris suum | 5 | 2021 | 32 | 1.150 |
Why?
|
Mice, Inbred BALB C | 29 | 2023 | 1001 | 1.090 |
Why?
|
Vaccines, Synthetic | 15 | 2022 | 316 | 1.030 |
Why?
|
Chagas Disease | 8 | 2023 | 295 | 1.010 |
Why?
|
Animals | 101 | 2024 | 34298 | 0.990 |
Why?
|
Trypanosoma cruzi | 7 | 2023 | 236 | 0.990 |
Why?
|
Adjuvants, Immunologic | 18 | 2022 | 381 | 0.950 |
Why?
|
Cystatins | 5 | 2024 | 8 | 0.920 |
Why?
|
Spike Glycoprotein, Coronavirus | 8 | 2023 | 187 | 0.850 |
Why?
|
Filariasis | 3 | 2018 | 27 | 0.850 |
Why?
|
Brugia malayi | 3 | 2018 | 40 | 0.830 |
Why?
|
Vaccination | 18 | 2022 | 962 | 0.830 |
Why?
|
Retinol-Binding Proteins | 3 | 2018 | 21 | 0.790 |
Why?
|
Sepsis | 6 | 2023 | 482 | 0.780 |
Why?
|
Immunoglobulin G | 14 | 2024 | 779 | 0.770 |
Why?
|
Necatoriasis | 7 | 2018 | 37 | 0.770 |
Why?
|
Trichuriasis | 3 | 2022 | 31 | 0.760 |
Why?
|
Hookworm Infections | 6 | 2018 | 125 | 0.750 |
Why?
|
Intestinal Volvulus | 1 | 2022 | 38 | 0.750 |
Why?
|
Glutathione Transferase | 4 | 2013 | 156 | 0.750 |
Why?
|
Immunodominant Epitopes | 3 | 2015 | 50 | 0.740 |
Why?
|
Schistosoma japonicum | 4 | 2024 | 8 | 0.720 |
Why?
|
Tropomyosin | 5 | 2020 | 26 | 0.710 |
Why?
|
Complement C1q | 4 | 2024 | 19 | 0.680 |
Why?
|
Amino Acid Sequence | 18 | 2021 | 2715 | 0.650 |
Why?
|
Neglected Diseases | 2 | 2021 | 151 | 0.650 |
Why?
|
Immunoglobulin E | 6 | 2021 | 162 | 0.640 |
Why?
|
Immunization | 6 | 2022 | 308 | 0.620 |
Why?
|
Toxocariasis | 2 | 2015 | 27 | 0.610 |
Why?
|
Mice | 43 | 2024 | 17736 | 0.610 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 30 | 0.600 |
Why?
|
Parasitic Diseases | 1 | 2019 | 61 | 0.580 |
Why?
|
Cloning, Molecular | 13 | 2021 | 897 | 0.560 |
Why?
|
Gene Expression | 12 | 2021 | 1553 | 0.550 |
Why?
|
Communicable Disease Control | 1 | 2019 | 138 | 0.550 |
Why?
|
Antibodies, Protozoan | 9 | 2021 | 76 | 0.550 |
Why?
|
Saccharomycetales | 6 | 2021 | 37 | 0.540 |
Why?
|
Larva | 16 | 2019 | 248 | 0.500 |
Why?
|
Toxocara canis | 1 | 2015 | 5 | 0.500 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 2 | 2008 | 22 | 0.500 |
Why?
|
Cytokines | 16 | 2024 | 1288 | 0.480 |
Why?
|
Molecular Sequence Data | 18 | 2015 | 3894 | 0.470 |
Why?
|
Hypersensitivity | 4 | 2019 | 185 | 0.460 |
Why?
|
Antigenic Variation | 1 | 2014 | 39 | 0.460 |
Why?
|
Recombinant Fusion Proteins | 5 | 2023 | 772 | 0.460 |
Why?
|
Dogs | 13 | 2018 | 773 | 0.440 |
Why?
|
Disease Models, Animal | 18 | 2024 | 4405 | 0.440 |
Why?
|
Salivary Proteins and Peptides | 3 | 2020 | 19 | 0.430 |
Why?
|
Pichia | 10 | 2017 | 56 | 0.430 |
Why?
|
Immune Evasion | 4 | 2024 | 35 | 0.430 |
Why?
|
Onchocerca volvulus | 3 | 2019 | 15 | 0.410 |
Why?
|
Dendritic Cells | 5 | 2019 | 414 | 0.400 |
Why?
|
Basophils | 1 | 2012 | 11 | 0.400 |
Why?
|
Histamine Release | 1 | 2012 | 10 | 0.400 |
Why?
|
Calreticulin | 2 | 2024 | 20 | 0.400 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 30 | 0.400 |
Why?
|
Acute Lung Injury | 2 | 2024 | 63 | 0.380 |
Why?
|
Leishmania | 2 | 2023 | 29 | 0.380 |
Why?
|
Metalloendopeptidases | 5 | 2007 | 101 | 0.380 |
Why?
|
Host-Parasite Interactions | 5 | 2019 | 72 | 0.370 |
Why?
|
Helminths | 2 | 2022 | 48 | 0.370 |
Why?
|
Vaccines, DNA | 3 | 2016 | 48 | 0.370 |
Why?
|
Parasite Load | 7 | 2021 | 31 | 0.360 |
Why?
|
Antibodies, Viral | 6 | 2024 | 1153 | 0.360 |
Why?
|
Alum Compounds | 6 | 2022 | 41 | 0.360 |
Why?
|
Cricetinae | 7 | 2018 | 422 | 0.350 |
Why?
|
Anthelmintics | 3 | 2018 | 55 | 0.350 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2021 | 471 | 0.330 |
Why?
|
Heme | 1 | 2010 | 52 | 0.320 |
Why?
|
Antigens, Protozoan | 4 | 2021 | 66 | 0.320 |
Why?
|
Chagas Cardiomyopathy | 3 | 2019 | 48 | 0.320 |
Why?
|
DNA, Complementary | 6 | 2015 | 461 | 0.320 |
Why?
|
Saccharomyces cerevisiae | 5 | 2023 | 427 | 0.310 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2019 | 216 | 0.310 |
Why?
|
Soil | 3 | 2021 | 57 | 0.310 |
Why?
|
Trichuris | 3 | 2022 | 26 | 0.310 |
Why?
|
Leishmaniasis Vaccines | 2 | 2020 | 20 | 0.310 |
Why?
|
Th2 Cells | 6 | 2021 | 185 | 0.300 |
Why?
|
Gerbillinae | 3 | 2018 | 55 | 0.300 |
Why?
|
Programmed Cell Death 1 Receptor | 2 | 2020 | 128 | 0.300 |
Why?
|
Female | 44 | 2024 | 66836 | 0.290 |
Why?
|
Inflammation | 6 | 2023 | 1444 | 0.290 |
Why?
|
Ancylostomatoidea | 3 | 2018 | 60 | 0.280 |
Why?
|
Humans | 44 | 2024 | 125331 | 0.280 |
Why?
|
China | 6 | 2019 | 246 | 0.280 |
Why?
|
Variant Surface Glycoproteins, Trypanosoma | 2 | 2018 | 6 | 0.270 |
Why?
|
DNA, Helminth | 2 | 2010 | 22 | 0.270 |
Why?
|
Immunogenicity, Vaccine | 2 | 2019 | 106 | 0.270 |
Why?
|
N-Glycosyl Hydrolases | 2 | 2016 | 14 | 0.260 |
Why?
|
Psychodidae | 2 | 2017 | 14 | 0.260 |
Why?
|
Leishmania donovani | 2 | 2016 | 23 | 0.260 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 2018 | 70 | 0.260 |
Why?
|
Colitis | 2 | 2020 | 153 | 0.250 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2017 | 40 | 0.250 |
Why?
|
Hemeproteins | 1 | 2005 | 7 | 0.250 |
Why?
|
Toll-Like Receptor 2 | 3 | 2023 | 55 | 0.250 |
Why?
|
Hemolysin Proteins | 2 | 2018 | 30 | 0.250 |
Why?
|
Lung | 7 | 2024 | 1487 | 0.250 |
Why?
|
Protein Binding | 5 | 2024 | 1755 | 0.250 |
Why?
|
Endotoxins | 2 | 2018 | 48 | 0.250 |
Why?
|
Protozoan Proteins | 2 | 2016 | 111 | 0.240 |
Why?
|
Malaria, Falciparum | 2 | 2022 | 46 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 822 | 0.240 |
Why?
|
Plasmodium falciparum | 2 | 2022 | 64 | 0.230 |
Why?
|
Paraquat | 1 | 2024 | 13 | 0.230 |
Why?
|
Immunotherapy | 3 | 2018 | 679 | 0.230 |
Why?
|
Carrier Proteins | 3 | 2015 | 1033 | 0.220 |
Why?
|
Vaccines, Subunit | 5 | 2021 | 66 | 0.220 |
Why?
|
Echinococcus granulosus | 1 | 2023 | 2 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2022 | 396 | 0.220 |
Why?
|
Epitopes | 2 | 2016 | 433 | 0.220 |
Why?
|
Leukocytes, Mononuclear | 3 | 2020 | 325 | 0.220 |
Why?
|
Protein Domains | 5 | 2021 | 236 | 0.210 |
Why?
|
Spleen | 4 | 2016 | 280 | 0.210 |
Why?
|
Macrophages | 6 | 2024 | 625 | 0.210 |
Why?
|
Sequence Alignment | 7 | 2017 | 619 | 0.210 |
Why?
|
Leishmaniasis | 1 | 2023 | 34 | 0.210 |
Why?
|
Parasites | 1 | 2023 | 34 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2008 | 1292 | 0.200 |
Why?
|
Dextran Sulfate | 2 | 2020 | 47 | 0.200 |
Why?
|
Electron Transport Complex IV | 2 | 2001 | 39 | 0.200 |
Why?
|
Onchocerca | 1 | 2022 | 5 | 0.200 |
Why?
|
Ivermectin | 1 | 2022 | 7 | 0.200 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2014 | 1006 | 0.190 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 4418 | 0.190 |
Why?
|
Blindness | 1 | 2022 | 72 | 0.190 |
Why?
|
Complement Pathway, Classical | 2 | 2024 | 4 | 0.180 |
Why?
|
Immunoglobulin M | 2 | 2024 | 212 | 0.180 |
Why?
|
Immunomodulation | 2 | 2018 | 79 | 0.180 |
Why?
|
Neutrophils | 2 | 2020 | 381 | 0.180 |
Why?
|
DNA, Kinetoplast | 1 | 2020 | 3 | 0.180 |
Why?
|
Extracellular Traps | 1 | 2020 | 8 | 0.180 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2002 | 256 | 0.180 |
Why?
|
Cattle | 1 | 2022 | 567 | 0.180 |
Why?
|
Viral Vaccines | 2 | 2014 | 337 | 0.180 |
Why?
|
Bodily Secretions | 1 | 2020 | 7 | 0.180 |
Why?
|
Skin | 3 | 2012 | 521 | 0.180 |
Why?
|
Th1 Cells | 5 | 2022 | 153 | 0.180 |
Why?
|
Macrophages, Peritoneal | 1 | 2020 | 37 | 0.170 |
Why?
|
Immunity | 2 | 2018 | 192 | 0.170 |
Why?
|
Phlebotomus | 1 | 2020 | 17 | 0.170 |
Why?
|
Leishmaniasis, Cutaneous | 2 | 2020 | 48 | 0.170 |
Why?
|
Asthma | 2 | 2019 | 756 | 0.170 |
Why?
|
Phylogeny | 3 | 2020 | 688 | 0.170 |
Why?
|
Bacterial Proteins | 2 | 2018 | 887 | 0.170 |
Why?
|
Insect Proteins | 1 | 2020 | 101 | 0.170 |
Why?
|
Base Sequence | 6 | 2004 | 3108 | 0.170 |
Why?
|
Cell Polarity | 1 | 2020 | 121 | 0.170 |
Why?
|
Germinal Center | 1 | 2020 | 38 | 0.170 |
Why?
|
Coinfection | 1 | 2021 | 172 | 0.160 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2020 | 31 | 0.160 |
Why?
|
Cysteine | 2 | 2017 | 139 | 0.160 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2015 | 658 | 0.160 |
Why?
|
Tissue Extracts | 1 | 2019 | 13 | 0.160 |
Why?
|
B-Lymphocytes | 2 | 2020 | 533 | 0.160 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 125 | 0.160 |
Why?
|
Helminthiasis | 2 | 2021 | 79 | 0.160 |
Why?
|
Circular Dichroism | 1 | 2018 | 86 | 0.150 |
Why?
|
T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2018 | 1 | 0.150 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 199 | 0.150 |
Why?
|
Arthritis, Experimental | 1 | 2018 | 15 | 0.150 |
Why?
|
Bacillus thuringiensis | 1 | 2018 | 1 | 0.150 |
Why?
|
Protective Agents | 1 | 2018 | 35 | 0.150 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 52 | 0.150 |
Why?
|
Vitamin A | 1 | 2018 | 59 | 0.150 |
Why?
|
Blotting, Western | 2 | 2015 | 1109 | 0.150 |
Why?
|
Protein Structure, Secondary | 1 | 2018 | 238 | 0.150 |
Why?
|
Milk Proteins | 1 | 2018 | 92 | 0.150 |
Why?
|
Antibodies, Neutralizing | 4 | 2023 | 469 | 0.150 |
Why?
|
Orthomyxoviridae Infections | 1 | 2018 | 59 | 0.140 |
Why?
|
Interferon-gamma | 5 | 2019 | 505 | 0.140 |
Why?
|
Mice, Inbred ICR | 4 | 2020 | 149 | 0.140 |
Why?
|
Parasitemia | 4 | 2019 | 24 | 0.140 |
Why?
|
Male | 22 | 2024 | 61573 | 0.140 |
Why?
|
Superantigens | 1 | 2017 | 20 | 0.140 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 700 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 138 | 0.140 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 35 | 0.130 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2023 | 85 | 0.130 |
Why?
|
Salmonella typhimurium | 1 | 2016 | 43 | 0.130 |
Why?
|
Immunoglobulin A | 3 | 2024 | 207 | 0.130 |
Why?
|
Metalloproteases | 2 | 2007 | 15 | 0.130 |
Why?
|
14-3-3 Proteins | 1 | 2016 | 54 | 0.130 |
Why?
|
Prevalence | 3 | 2019 | 2466 | 0.130 |
Why?
|
Escherichia coli | 3 | 2015 | 984 | 0.130 |
Why?
|
Myocardial Infarction | 1 | 2023 | 1043 | 0.130 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2017 | 162 | 0.130 |
Why?
|
Lectins | 1 | 2015 | 54 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2016 | 114 | 0.120 |
Why?
|
Parasite Egg Count | 5 | 2012 | 28 | 0.120 |
Why?
|
Aging | 2 | 2018 | 1182 | 0.120 |
Why?
|
Serologic Tests | 1 | 2015 | 118 | 0.120 |
Why?
|
Cardiomyopathies | 1 | 2020 | 500 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2020 | 12290 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 140 | 0.110 |
Why?
|
Endemic Diseases | 2 | 2024 | 57 | 0.110 |
Why?
|
Middle East Respiratory Syndrome Coronavirus | 1 | 2014 | 22 | 0.110 |
Why?
|
Genome, Helminth | 1 | 2014 | 10 | 0.110 |
Why?
|
Immune Sera | 2 | 2004 | 95 | 0.110 |
Why?
|
Immunization, Secondary | 1 | 2014 | 104 | 0.110 |
Why?
|
Ascaris lumbricoides | 1 | 2014 | 19 | 0.110 |
Why?
|
Immunity, Cellular | 3 | 2022 | 206 | 0.110 |
Why?
|
Schistosomiasis mansoni | 1 | 2013 | 24 | 0.110 |
Why?
|
Tetraspanins | 1 | 2013 | 30 | 0.110 |
Why?
|
Survival Analysis | 4 | 2018 | 1493 | 0.100 |
Why?
|
Crystallography, X-Ray | 3 | 2024 | 357 | 0.100 |
Why?
|
Influenza Vaccines | 1 | 2018 | 481 | 0.100 |
Why?
|
Molecular Weight | 3 | 2020 | 387 | 0.100 |
Why?
|
Peptides | 2 | 2020 | 812 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2005 | 2810 | 0.100 |
Why?
|
Complement Activation | 2 | 2024 | 52 | 0.100 |
Why?
|
Mozambique | 2 | 2022 | 20 | 0.100 |
Why?
|
Biological Products | 1 | 2014 | 122 | 0.100 |
Why?
|
Molecular Docking Simulation | 2 | 2024 | 110 | 0.100 |
Why?
|
Immunoglobulins | 1 | 2012 | 173 | 0.090 |
Why?
|
Colon | 1 | 2014 | 352 | 0.090 |
Why?
|
Administration, Intranasal | 2 | 2022 | 132 | 0.090 |
Why?
|
Esophagus | 2 | 2011 | 223 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2020 | 3751 | 0.090 |
Why?
|
Mice, Inbred AKR | 2 | 2022 | 14 | 0.090 |
Why?
|
Mesocricetus | 3 | 2012 | 72 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 2057 | 0.080 |
Why?
|
Genetic Vectors | 3 | 2020 | 940 | 0.080 |
Why?
|
Factor Xa Inhibitors | 1 | 2011 | 64 | 0.080 |
Why?
|
Aluminum Hydroxide | 1 | 2010 | 41 | 0.080 |
Why?
|
Lipid Peroxidation | 1 | 2010 | 96 | 0.080 |
Why?
|
Open Reading Frames | 1 | 2010 | 211 | 0.080 |
Why?
|
Mucous Membrane | 2 | 2022 | 89 | 0.080 |
Why?
|
Lipopolysaccharides | 2 | 2023 | 297 | 0.080 |
Why?
|
Binding Sites | 3 | 2018 | 1305 | 0.080 |
Why?
|
Protein Conformation | 2 | 2024 | 836 | 0.080 |
Why?
|
Matrix Metalloproteinases, Secreted | 1 | 2008 | 4 | 0.080 |
Why?
|
Coronavirus Infections | 1 | 2014 | 361 | 0.080 |
Why?
|
Ovalbumin | 2 | 2019 | 319 | 0.080 |
Why?
|
Glutathione | 1 | 2010 | 195 | 0.080 |
Why?
|
Interleukin-5 | 2 | 2018 | 43 | 0.070 |
Why?
|
Viral Load | 2 | 2021 | 388 | 0.070 |
Why?
|
Interleukin-4 | 2 | 2018 | 140 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 309 | 0.070 |
Why?
|
Species Specificity | 2 | 2014 | 551 | 0.070 |
Why?
|
Dog Diseases | 2 | 2005 | 50 | 0.070 |
Why?
|
Fatty Acids | 2 | 2015 | 343 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 2522 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2012 | 344 | 0.070 |
Why?
|
Immunologic Factors | 2 | 2020 | 173 | 0.070 |
Why?
|
Interleukin-10 | 2 | 2018 | 174 | 0.070 |
Why?
|
Monocytes | 2 | 2019 | 345 | 0.070 |
Why?
|
Pandemics | 1 | 2014 | 1112 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2018 | 80 | 0.060 |
Why?
|
Intestines | 4 | 2004 | 577 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 84 | 0.060 |
Why?
|
Connective Tissue | 1 | 2006 | 24 | 0.060 |
Why?
|
Anticoagulants | 1 | 2011 | 577 | 0.060 |
Why?
|
Forkhead Transcription Factors | 2 | 2019 | 359 | 0.060 |
Why?
|
Herbicides | 1 | 2024 | 12 | 0.060 |
Why?
|
Chromatography, Gel | 2 | 2016 | 95 | 0.060 |
Why?
|
Myocardium | 2 | 2020 | 1021 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2004 | 118 | 0.060 |
Why?
|
Cyst Fluid | 1 | 2023 | 6 | 0.060 |
Why?
|
Seroepidemiologic Studies | 1 | 2024 | 122 | 0.060 |
Why?
|
Africa | 1 | 2024 | 133 | 0.060 |
Why?
|
Africa South of the Sahara | 1 | 2024 | 115 | 0.060 |
Why?
|
Adult | 7 | 2024 | 29607 | 0.050 |
Why?
|
Cysteine Endopeptidases | 1 | 2004 | 114 | 0.050 |
Why?
|
Gene Library | 1 | 2004 | 218 | 0.050 |
Why?
|
Malaria | 1 | 2024 | 87 | 0.050 |
Why?
|
Vaccines, Combined | 1 | 2023 | 39 | 0.050 |
Why?
|
Antigens, CD | 2 | 2016 | 430 | 0.050 |
Why?
|
DNA, Mitochondrial | 2 | 2001 | 211 | 0.050 |
Why?
|
Europe | 1 | 2024 | 357 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2005 | 1703 | 0.050 |
Why?
|
Caenorhabditis elegans | 2 | 2015 | 226 | 0.050 |
Why?
|
Anemia | 1 | 2007 | 339 | 0.050 |
Why?
|
Schistosoma | 1 | 2022 | 10 | 0.050 |
Why?
|
Technology | 1 | 2023 | 63 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2021 | 2901 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2022 | 120 | 0.050 |
Why?
|
Immunity, Mucosal | 1 | 2022 | 87 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2016 | 2371 | 0.050 |
Why?
|
Heart | 2 | 2016 | 731 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2001 | 289 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 292 | 0.050 |
Why?
|
Antibody Formation | 1 | 2022 | 266 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 2021 | 1719 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2021 | 180 | 0.040 |
Why?
|
RAW 264.7 Cells | 1 | 2020 | 40 | 0.040 |
Why?
|
DNA, Protozoan | 1 | 2020 | 31 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 64 | 0.040 |
Why?
|
Fermentation | 1 | 2020 | 66 | 0.040 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2020 | 52 | 0.040 |
Why?
|
Genetics, Population | 1 | 2001 | 188 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 125 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 161 | 0.040 |
Why?
|
Feces | 3 | 2012 | 727 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2021 | 490 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2020 | 263 | 0.040 |
Why?
|
Adolescent | 5 | 2024 | 19419 | 0.040 |
Why?
|
Autoimmunity | 1 | 2020 | 172 | 0.040 |
Why?
|
Anti-Allergic Agents | 1 | 2019 | 27 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2020 | 71 | 0.040 |
Why?
|
Biomarkers | 2 | 2019 | 3093 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2021 | 767 | 0.040 |
Why?
|
Chemokines | 1 | 2019 | 133 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 9066 | 0.040 |
Why?
|
Peptide Mapping | 1 | 2018 | 44 | 0.040 |
Why?
|
Ligands | 2 | 2015 | 538 | 0.040 |
Why?
|
Ascaris | 1 | 2018 | 10 | 0.040 |
Why?
|
Rats | 3 | 2020 | 3725 | 0.040 |
Why?
|
Swine Diseases | 1 | 2018 | 37 | 0.040 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2020 | 508 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2018 | 149 | 0.040 |
Why?
|
Eosinophils | 1 | 2019 | 120 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2018 | 21 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2018 | 26 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2018 | 97 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 1586 | 0.040 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2018 | 41 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2017 | 54 | 0.040 |
Why?
|
Cholera Toxin | 1 | 2017 | 49 | 0.030 |
Why?
|
Cecum | 1 | 2017 | 27 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 439 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 586 | 0.030 |
Why?
|
Hydrolysis | 1 | 2017 | 161 | 0.030 |
Why?
|
Drug Carriers | 1 | 2017 | 99 | 0.030 |
Why?
|
Pyroglyphidae | 1 | 2016 | 9 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2016 | 15 | 0.030 |
Why?
|
Receptors, CCR10 | 1 | 2016 | 1 | 0.030 |
Why?
|
Receptors, CCR | 1 | 2016 | 2 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2016 | 8 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 81 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2017 | 129 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2017 | 290 | 0.030 |
Why?
|
Serine | 1 | 2017 | 175 | 0.030 |
Why?
|
Complement C8 | 1 | 2015 | 1 | 0.030 |
Why?
|
Complement C9 | 1 | 2015 | 3 | 0.030 |
Why?
|
Vaccines, Attenuated | 1 | 2016 | 175 | 0.030 |
Why?
|
Body Weight | 2 | 2014 | 989 | 0.030 |
Why?
|
Cell Line | 1 | 2021 | 2754 | 0.030 |
Why?
|
Dynamic Light Scattering | 1 | 2016 | 8 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 404 | 0.030 |
Why?
|
Workflow | 1 | 2016 | 118 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2016 | 135 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 1763 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 326 | 0.030 |
Why?
|
Genes, Helminth | 1 | 2015 | 22 | 0.030 |
Why?
|
Lipid A | 1 | 2015 | 23 | 0.030 |
Why?
|
Hemolysis | 1 | 2015 | 111 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2016 | 128 | 0.030 |
Why?
|
Child | 4 | 2022 | 24575 | 0.030 |
Why?
|
Crystallization | 1 | 2015 | 83 | 0.030 |
Why?
|
Mutagenesis | 1 | 2016 | 345 | 0.030 |
Why?
|
Sus scrofa | 1 | 2015 | 122 | 0.030 |
Why?
|
Swine | 1 | 2018 | 1178 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2017 | 420 | 0.030 |
Why?
|
Erythrocytes | 1 | 2015 | 219 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2015 | 88 | 0.030 |
Why?
|
Equipment Design | 1 | 2016 | 589 | 0.030 |
Why?
|
Adenoviridae | 1 | 2017 | 605 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2017 | 372 | 0.030 |
Why?
|
Administration, Oral | 1 | 2016 | 681 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 75 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 682 | 0.030 |
Why?
|
Aged | 4 | 2024 | 19728 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 45 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2017 | 485 | 0.030 |
Why?
|
Muscles | 1 | 2014 | 292 | 0.030 |
Why?
|
Glycosylation | 1 | 2013 | 124 | 0.030 |
Why?
|
Schistosoma mansoni | 1 | 2013 | 24 | 0.030 |
Why?
|
Technology, Pharmaceutical | 1 | 2013 | 20 | 0.030 |
Why?
|
Reproduction | 1 | 2015 | 237 | 0.030 |
Why?
|
Nanoparticles | 1 | 2016 | 230 | 0.030 |
Why?
|
Biotechnology | 1 | 2013 | 56 | 0.030 |
Why?
|
Transcriptome | 1 | 2019 | 977 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 398 | 0.030 |
Why?
|
Isoenzymes | 1 | 2013 | 232 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 1756 | 0.030 |
Why?
|
Models, Molecular | 1 | 2016 | 1084 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 26807 | 0.020 |
Why?
|
Viral Proteins | 1 | 2014 | 347 | 0.020 |
Why?
|
Lymphocytes | 1 | 2014 | 408 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 317 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2014 | 378 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 945 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 6318 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2014 | 801 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2016 | 3041 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2011 | 123 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 14123 | 0.020 |
Why?
|
Global Health | 1 | 2014 | 566 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 461 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 199 | 0.010 |
Why?
|
Sex Ratio | 1 | 2004 | 11 | 0.010 |
Why?
|
Hemoglobins | 1 | 2005 | 309 | 0.010 |
Why?
|
Regression Analysis | 1 | 2005 | 780 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 5900 | 0.010 |
Why?
|
Brazil | 1 | 2003 | 123 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2004 | 291 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2005 | 213 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 2003 | 194 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2005 | 6555 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 657 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 1242 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 7219 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 1104 | 0.010 |
Why?
|
Haplotypes | 1 | 2001 | 521 | 0.010 |
Why?
|
Research Design | 1 | 2003 | 693 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 1189 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 1282 | 0.010 |
Why?
|
Radiation Injuries, Experimental | 1 | 1967 | 22 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 1704 | 0.010 |
Why?
|
Age Factors | 1 | 2002 | 2824 | 0.010 |
Why?
|
Diet | 1 | 1967 | 1140 | 0.010 |
Why?
|
Risk Factors | 1 | 2002 | 10287 | 0.000 |
Why?
|
Edible Grain | 1 | 1967 | 45 | 0.000 |
Why?
|
Lactobacillus | 1 | 1967 | 45 | 0.000 |
Why?
|
Enterobacteriaceae | 1 | 1967 | 35 | 0.000 |
Why?
|
Meat | 1 | 1967 | 48 | 0.000 |
Why?
|
Lactose | 1 | 1967 | 54 | 0.000 |
Why?
|